Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.00
Oct 30 • 3:59 PM ET Dollar change-0.31 Percentage change(-9.37%)
Aftermarket Close
3.05
Aftermarket • 4:15 PM ET Dollar change+0.05 Percentage change(1.67%)
Index
-
Market Cap
29.40M
Enterprise Value
47.56M
Income
-41.86M
Sales
21.00M
Book/sh
7.50
Cash/sh
1.45
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
165
IPO
Apr 09, 2013
P/E
-
Forward P/E
-
PEG
-
P/S
1.40
P/B
0.40
P/C
2.06
P/FCF
-
EV/EBITDA
-
EV/Sales
2.26
Quick Ratio
1.92
Current Ratio
2.31
Debt/Eq
0.59
LT Debt/Eq
0.58
Option/Short
No / Yes
EPS (ttm)
-7.49
EPS next Y
-2.52
EPS next Q
-0.95
EPS this Y
60.70%
EPS next Y
36.63%
EPS next 5Y
45.15%
EPS past 3/5Y
41.57% 38.06%
Sales past 3/5Y
-6.84% 24.17%
EPS Y/Y TTM
62.36%
Sales Y/Y TTM
-22.65%
EPS Q/Q
78.49%
Sales Q/Q
-3.58%
Insider Own
25.07%
Insider Trans
0.59%
Inst Own
8.74%
Inst Trans
0.54%
ROA
-32.34%
ROE
-55.65%
ROIC
-38.12%
Gross Margin
58.15%
Oper. Margin
-151.60%
Profit Margin
-199.33%
SMA20
-34.44%
SMA50
-49.82%
SMA200
-61.27%
Trades
Shs Outstand
9.80M
Shs Float
7.34M
52W High
14.77 -79.69%
52W Low
3.01 -0.33%
Volatility
14.16% 14.10%
ATR (14)
0.54
RSI (14)
23.26
Beta
1.10
Rel Volume
1.53
Avg Volume
36.20K
Volume
55,534
Perf Week
-20.42%
Perf Month
-51.30%
Perf Quarter
-57.75%
Perf Half Y
-58.90%
Perf YTD
-73.64%
Perf Year
-78.04%
Perf 3Y
-89.21%
Perf 5Y
-99.08%
Perf 10Y
-99.77%
Prev Close
3.31
Price
3.00
Change %
-9.37%
Consensus
Strong Buy
Avg. Price Target
$9.20
Implied Upside
+206.7%
Analysts8incl. previous ratings
Rating Distribution7 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 27, 2026Initiated
BBTIG Research
Buy$6+100.0%
Aug 19, 2026Initiated
AAlliance Global Partners
Buy$12+300.0%
Jan 29, 2025Downgrade
TD logoTTD Cowen
Buy → Hold$2 → $1-66.7%
May 13, 2022Upgrade
AAlliance Global Partners
Neutral → Buy$8.75+191.7%
Apr 22, 2021Initiated
CCowen
Outperform$31+933.3%
Mar 23, 2021Initiated
SF logoSStifel
Buy$30+900.0%
Feb 25, 2021Initiated
CCantor Fitzgerald
Overweight$35+1,066.7%
Feb 01, 2021Downgrade
AAlliance Global Partners
Buy → Neutral$15.60 → $22.25+641.7%
Aug 17, 2020Initiated
AAegis Capital
Buy$25+733.3%
Aug 29, 2017Initiated
AAegis Capital
Buy$3.50+16.7%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matheis DennisDirectorJul 23 '26Buy6.9314,430100,00043,026Jul 28 05:27 PM
DarioHealth Corp. is a digital health company which offers a user-centric and multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.
CEO & DirectorMr. Erez Raphael
CFOMs. Chen Franco-Yehuda
ConsultantMr. Steven C. Nelson
Co-Founder & Production ChiefDov Oppenheim
Chief Operations OfficerLara Dodo